These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8355033)

  • 21. Health system reform and clinical research.
    Coleman T
    Oncology (Williston Park); 1995 Feb; 9(2):118, 121, 126. PubMed ID: 8771095
    [No Abstract]   [Full Text] [Related]  

  • 22. Type of oncology specialist and treatment-related outcomes in ovarian cancer.
    Hoffman MA; Iqbal U
    J Clin Oncol; 2007 Aug; 25(23):3553; author reply 3557-8. PubMed ID: 17687165
    [No Abstract]   [Full Text] [Related]  

  • 23. From 3D to 5D radiotherapy: a blitzkrieg of DTH!
    Sarin R
    J Cancer Res Ther; 2009; 5(4):223-4. PubMed ID: 20160353
    [No Abstract]   [Full Text] [Related]  

  • 24. ALS lessons learned from other neurological diseases. Neuro-oncology.
    Schold SC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():34-5. PubMed ID: 15512867
    [No Abstract]   [Full Text] [Related]  

  • 25. IT infrastructure components to support clinical care and translational research projects in a comprehensive cancer center.
    Prokosch HU; Ries M; Beyer A; Schwenk M; Seggewies C; Köpcke F; Mate S; Martin M; Bärthlein B; Beckmann MW; Stürzl M; Croner R; Wullich B; Ganslandt T; Bürkle T
    Stud Health Technol Inform; 2011; 169():892-6. PubMed ID: 21893875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The organizational forms of research, their financial and technical support and introduction].
    Chissov VI; Starinskiĭ VV; Proshchenko VG; Shabashova NIa; Golovinova IN
    Vopr Onkol; 1991; 37(6):657-66. PubMed ID: 1843141
    [No Abstract]   [Full Text] [Related]  

  • 27. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

  • 28. Some notable properties of the standard oncology Phase I design.
    Hather GJ; Mackey H
    J Biopharm Stat; 2009; 19(3):543-55. PubMed ID: 19384695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology is a necessary and informative tool in oncology clinical trials.
    Nagtegaal ID; West NP; van Krieken JH; Quirke P
    J Pathol; 2014 Jan; 232(2):185-9. PubMed ID: 24037805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
    Steensma DP
    J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
    [No Abstract]   [Full Text] [Related]  

  • 31. Emerging innovations in clinical trial design.
    Berry DA
    Clin Pharmacol Ther; 2016 Jan; 99(1):82-91. PubMed ID: 26561040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncology of companion animals as a model for humans. an overview of tumor histotypes.
    Porrello A; Cardelli P; Spugnini EP
    J Exp Clin Cancer Res; 2006 Mar; 25(1):97-105. PubMed ID: 16761625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional wisdom and activities of the middle range.
    Jones B; Dale RG; Carabe A
    Br J Radiol; 2005 Dec; 78(936):1119. PubMed ID: 16352590
    [No Abstract]   [Full Text] [Related]  

  • 34. American Society of Clinical Oncology: Policy for relationships with companies.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
    Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
    Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally.
    Dalton WS; Sullivan DM; Yeatman TJ; Fenstermacher DA
    Clin Cancer Res; 2010 Dec; 16(24):5987-96. PubMed ID: 21169252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development.
    Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2038-41. PubMed ID: 17119025
    [No Abstract]   [Full Text] [Related]  

  • 38. An audience with...Joseph Bolen. Interview by Bethan Hughes.
    Bolen J
    Nat Rev Drug Discov; 2009 Aug; 8(8):608. PubMed ID: 19644470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness research: opportunities in surgical oncology.
    Neuman HB; Greenberg CC
    Semin Radiat Oncol; 2014 Jan; 24(1):43-8. PubMed ID: 24314341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From the editor. Bridging the gap between biostatistician and oncologist.
    Bates SE
    Clin Cancer Res; 2008 Oct; 14(19):5953. PubMed ID: 18829472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.